glutathion nebulized for cystic fibrosis Gene therapy being used in study | Newsroom New advances in the therapy
Description
The secondary outcomes to be measured include the safety of both administration routes, quality of life (measured using the EuroQoL-5D questionnaire) and adherence to treatment
BPC-157 accelerates tissue repair across tendon, ligament, muscle, and epithelial models by modulating nitric oxide pathways, upregulating VEGF and other growth factors, and promoting fibroblast migration 4
Rees, W
3 Biotech 8, 334
